Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell engulfment defines spatially distinct competitive metabolic niches associated with clinical outcomes in colorectal cancer.

Cell death and differentiation·2026
Same author

Hexanoic acid inhibits in vitro growth and biofilm formation in Xanthomonas vesicatoria and Xanthomonas euvesicatoria.

Microbiological research·2026
Same author

Fluorescent TAPY-bodipy dyads as tools for imaging fungal mitochondria by confocal microscopy and flow cytometry.

Analytical and bioanalytical chemistry·2026
Same author

A Review on Pulsed Laser-Based Synthesis of Carbon and Graphene Quantum Dots in Liquids: From Fundamentals, Chemistry to Bio Applications and Beyond.

The journal of physical chemistry. C, Nanomaterials and interfaces·2025
Same author

Minimalistic bis-triarylpyridinium cations: effective antimicrobials against bacterial and fungal pathogens.

RSC medicinal chemistry·2025
Same author

Synthesis and Biological Evaluation of New <i>cis</i>-Restricted Triazole Analogues of Combretastatin A-4.

Molecules (Basel, Switzerland)·2025

Related Experiment Video

Updated: May 16, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.6K

Introducing TAPY as a Versatile Alternative to TPP for Selective Mitochondrial Targeting in Cancer Cells.

Jean C Neto1, Federico Lucantoni2, Leydy V González1

  • 1Universitat Jaume I de Castellón, Departamento de Química Inorgánica y Orgánica, Avda. Vicente Sos Baynat s/n, 12071 Castellón de la Plana, Spain.

Bioconjugate Chemistry
|March 31, 2025
PubMed
Summary

Researchers developed novel TAPY-bodipy (BDP) dyads for targeted mitochondrial imaging in cancer cells. These compounds selectively accumulated in cancer cell mitochondria, outperforming traditional triphenylphosphonium (TPP) derivatives for enhanced fluorescence imaging.

More Related Videos

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions
10:26

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions

Published on: December 20, 2017

9.4K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

13.2K

Related Experiment Videos

Last Updated: May 16, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.6K
Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions
10:26

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions

Published on: December 20, 2017

9.4K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

13.2K

Area of Science:

  • Mitochondrial research
  • Cell biology
  • Organic chemistry

Background:

  • Mitochondrial function is crucial for understanding diseases like cancer and aging.
  • Optical techniques, particularly fluorescence imaging microscopy, are vital for studying subcellular structures like mitochondria.
  • Triphenylphosphonium (TPP) cations are established mitochondrial imaging agents.

Purpose of the Study:

  • To explore novel triarylpyridinium (TAPY) cations as mitochondrial carriers.
  • To synthesize and characterize TAPY-bodipy (BDP) dyads for selective mitochondrial targeting.
  • To evaluate the potential of TAPY derivatives as alternatives to TPP for cancer cell imaging.

Main Methods:

  • Synthesis and chemical characterization of six TAPY-BDP dyads.
  • Confocal Laser Scanning Microscopy (CLSM) for cellular uptake studies.
  • Comparative analysis with a TPP-BDP model compound in cancer cells (MCF-7).

Main Results:

  • TAPY-BDP dyads were selectively delivered to mitochondria in cancer cell lines (MCF-7, A549, HT-29).
  • These dyads did not target mitochondria in normal cells (HEK-293, HMEC-1), indicating potential for cancer cell differentiation.
  • A TAPY(OMe)-BDP dyad achieved double the fluorescence intensity compared to the TPP derivative in MCF-7 cells.

Conclusions:

  • TAPY cations represent a promising new class of mitochondrial targeting agents.
  • TAPY-BDP dyads demonstrate selective uptake in cancer cell mitochondria, offering potential for cancer diagnostics.
  • The chemical versatility of TAPY cations allows for future optimization as advanced mitochondrial imaging tools.